ELICERA THERAPEUTICS AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.065 SEK | +8.67% |
|
+12.34% | -76.64% |
| 28/03 | Elicera Therapeutics AB Announces Director Changes | CI |
| 06/03 | Elicera Enters Agreement with Prominent US Cancer Center to Evaluate the Use of ITANK in T-Cell Receptor Therapies | CI |
Chart calendar Elicera Therapeutics AB
0cb82abdeb9560d.7mvWZrIM7ZV91ge2zZ-F-NANPUbxR6gjpXX5KZ7FLlw.ryegCIN4wKAtk33yjPbTyLY_aiHBM-F6wwXAc9G_QQa-Ib8N23q8pQzlVg~db9e431b5cf6bc59dd343ee31e642622
Upcoming events on Elicera Therapeutics AB
Past events on Elicera Therapeutics AB
| 23/04/2024 | Q1 2024 Earnings Release (Projected) |
| 13/02/2024 | Q4 2023 Earnings Release |
| 14/11/2023 | Q3 2023 Earnings Release |
| 25/10/2023 | BioStock Life Science Fall Summit |
| 29/08/2023 | Q2 2023 Earnings Release |
| 16/05/2023 | Annual General Meeting |
| 16/05/2023 | Q1 2023 Earnings Release |
| 17/02/2023 | FY 2022 Earnings Release |
| 18/11/2022 | Q3 2022 Earnings Release |
| 22/08/2022 11:36 am | Interim 2022 Earnings Release |
| 26/04/2022 11:32 am | Q1 2022 Earnings Release |
| 07/03/2022 | Annual General Meeting |
| 25/01/2022 | FY 2021 Earnings Release |
| 18/11/2021 01:15 pm | Q3 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,00 | 0,00 0,00 - | 11,2 11,0 2.09% | 0,00 |
|
EBITDA Million SEK | Released Forecast Spread | 0,00 | -19,4 -21,8 11.23% | -17,1 -19,0 10.08% | -49,0 |
|
EBIT Million SEK | Released Forecast Spread | 0,00 | -19,4 -21,8 11.18% | -17,1 -19,0 10.02% | -49,0 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | -48,0 |
|
Net income Million SEK | Released Forecast Spread | -13,1 | 0,00 0,00 - | 0,00 0,00 - | -48,0 |
|
EPS SEK | Released Forecast Spread | -0,82 | 0,00 0,00 - | 0,00 0,00 - | -2,40 |
| Announcement Date | 25/01/22 | 17/02/23 | 13/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q4 |
|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,00 0,00 - |
|
EBITDA Million SEK | Released Forecast Spread | -3,95 -6,40 38.3% |
|
EBIT Million SEK | Released Forecast Spread | -3,95 -6,40 38.25% |
| Announcement Date | 17/02/23 |
More events
Past sector events for Elicera Therapeutics AB
| 17/05/2024 | J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 17/05/2024 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 15/05/2024 07:35 pm | MANKIND PHARMA LIMITED: Q4 2024 Earnings Release |
| 15/05/2024 11:00 am | DERMAPHARM HOLDING SE: Q1 2024 Earnings Release |
| 15/05/2024 05:10 pm | CRESCO LABS INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:33 pm | GRANULES INDIA LIMITED: Q4 2024 Earnings Release |
| 15/05/2024 | EISAI CO., LTD.: Q4 2023 Earnings Release |
| 15/05/2024 03:13 am | LIQUIDIA CORPORATION: Q1 2024 Earnings Release |
| 14/05/2024 02:22 pm | BORA PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
| 14/05/2024 11:00 am | BAYER AG: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ELIC Stock
- Calendar Elicera Therapeutics AB
